|
Webster K. Cavenee, Ph.D. (Chair)
Director, Ludwig Institute for Cancer Research
Professor of Medicine
University of California, San Diego
Daniel J. Brat, M.D., Ph.D.,
Professor, Pathology & Laboratory Medicine
Emory University Hospital
Xandra O. Breakefield, Ph.D.
Professor of Neurology, Harvard Medical School
Geneticist in Neurology, Center for Human Genetics Research
Massachusetts General Hospital
Robert M. Friedlander, M.D.
Professor of Neurosurgery
Harvard Medical School
Vice Chairman Department of Neurosurgery Research
Brigham and Women's Hospital
Associate Director of Cerebrovascular Surgery
Director of Neuroapoptosis Laboratory
Robert B. Jenkins, M.D., Ph.D.
Professor of Laboratory Medicine
Mayo Clinic
David H. Gutmann, M.D., Ph.D.
Donald O. Schnuck Family Professor of Neurology
Washington University School of Medicine
Co-director, Neuro-Oncology Program
Washington University/Alvin J. Siteman Cancer Center
Director, Neurofibromatosis Center at Washington University
David H. Rowitch, M.D., Ph.D.
Investigator, Howard Hughes Medical Institute
Professor of Pediatrics and Neurological Surgery
University of California San Francisco School of Medicine
Dinah Sah, Ph.D.
Senior Director, Research
Alnylam Pharmaceuticals, Inc.
W. K. Alfred Yung, M.D.
Professor and Chairman
Department of Neuro-Oncology
M.D. Anderson Cancer Center
University of Texas
| 
